Yiling Wanzhou International Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding from Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Yiling Wanzhou International Pharmaceutical Co., Ltd. announced that it will receive CNY 300,000,000 from returning investor Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) on March 24, 2017. On same day the transaction is approved in 6th directorate’s 2nd meeting and also approved in its 2nd supervisory board’s 2nd meeting.